← Back to Search

Web-Based App for Sickle Cell Disease

N/A

Recruiting

Research Sponsored by Medical University of South Carolina

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be younger than 65 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up baseline and 1, 3, 6, 9, 12 months

Awards & highlights

Study Summary

This trial tests a web-based app to help teens and young adults with SCD manage their symptoms. #SickleCell #SCD #MobileHealth

Who is the study for?

This trial is for teens and young adults with any type of Sickle Cell Disease who own a mobile device compatible with the app, have internet access, and can understand English. It's not for those planning to move or transition to adult care soon, or with neurocognitive issues affecting their ability to participate.Check my eligibility

What is being tested?

The study is testing if a web-based mobile app called Voice Crisis Alert V2 along with electronic educational materials can help manage sickle cell disease by teaching patients about symptom care.See study design

What are the potential side effects?

Since this trial involves an educational mobile app and online materials rather than medication, traditional side effects are not expected; however, users may experience eye strain or headache from screen use.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ baseline and 1, 3, 6, 9, 12 months

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~baseline and 1, 3, 6, 9, 12 months

This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline and 1, 3, 6, 9, 12 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Self-management behaviors

Secondary outcome measures

Engagement in intervention/control (categorical)

Engagement in intervention/control (continuous)

Health-related quality of life

+5 more

Other outcome measures

Anxiety

Depressive symptoms

Family functioning

+8 more

Trial Design

2Treatment groups

Experimental Treatment

Active Control

Group I: InterventionExperimental Treatment1 Intervention

Study participants randomized to receive the intervention.

Group II: ControlActive Control1 Intervention

Study participants randomized to receive enhanced usual care (control).

Treatment

First Studied

Drug Approval Stage

How many patients have taken this drug

Voice Crisis Alert V2

2018

N/A

~60

Do I qualify?Apply below to find out

Find a Location

Who is running the clinical trial?

National Institute of Nursing Research (NINR)NIH

580 Previous Clinical Trials

10,376,289 Total Patients Enrolled

Medical University of South CarolinaLead Sponsor

933 Previous Clinical Trials

7,394,364 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Does this medical trial include participants over 45 years old?

"The age range for this medical trial is between 14 and 21 years old."

Answered by AI

What are the eligibility criteria for participating in this research project?

"This medical trial is seeking 272 participants that have been diagnosed with sickle cell disease and are between the ages of 14 and 21."

Answered by AI

Are there any openings in the current clinical trial?

"It appears that this trial has already closed its recruitment period, having been initially posted on October 1st 2023 and last edited on September 6th 2023. Despite the closure of this medical study, 185 other trials are still open for enrollment at present."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

SMYLS Multi-site Trial

Shannon Phillips 2024. "SMYLS Multi-site Trial". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT06035939.